Denise Yardley, MD, GCRA
Specialities
- Breast cancer
- Benign-hematology
- Clinical trials and research advancements
Education
Medical Degree: Medical College of Georgia
Residency: University of Texas Southwestern Medical Center
Fellowship: University of Texas Southwestern Medical Center
Certifications/Memberships
Genomics Cancer Risk Assessment
Member of the Clinical Cancer Genomics Community of Practice
Location
335 24th Avenue North, Suite 200
Nashville, Tennessee 37203
Phone: 615-329-7640
Fax: 615-234-7723
Language
English
Biography
Dr. Yardley is a board-certified medical oncologist and hematologist at SCRI Oncology Partners and serves as the associate director of breast cancer research at SCRI. Prior to joining the team at SCRI, she served as the medical director at the University of Texas Southwestern’s Center for Breast Care. A diplomate of the American Board of Internal Medicine, Medical Oncology and Hematology, she is also a recipient of the American Cancer Society Clinical Oncology Career Development Award. Dr. Yardley has been caring for patients in Nashville for over 20 years.
Philosophy
Dr. Yardley is passionate about providing access to the latest advancements in breast cancer care. She approaches each patient and their family members with knowledge and compassion. She provides individualized treatment plans tailored to each patient’s unique needs and goals for their health.
"Relevant
SCRI Oncology Partners Launches New Center for Breast Health and High-Risk Clinic to Advance Care and Empower Patients
Nashville, Tenn. Sept. 24, 2025 — SCRI Oncology Partners, a leading cancer treatment center led by internationally renowned oncology experts, proudly announces the opening of its new Center for Breast Health, featuring a specialized High-Risk Clinic. This...
How to Detect Skin Cancer
Skin cancer is the most common form of cancer in the United States with more people being diagnosed each year than all other cancers combined. Knowing what to look for can help catch it early when it’s much easier to treat.
Six Must-Knows about Bladder Cancer
Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.
SCRI Oncology Partners Welcomes Hans Lee, MD, and Cody Lebeck Lee, MD to Provide Expert Cancer Care to Tennessee Community
SCRI Oncology Partners, a dedicated cancer treatment center led by globally recognized oncology experts, is proud to welcome Hans Lee, MD, and Cody Lebeck Lee, MD to the practice.
What to Know About Testicular Cancer
April is National Testicular Cancer Awareness Month, and at SCRI Oncology Partners, we recognize it is a crucial time to spotlight the importance of awareness and research in the fight against this disease. Testicular cancer predominantly impacts young and middle-aged...
The Importance of Health Screenings for Colorectal Cancer
As March ushers in National Colorectal Cancer Awareness Month, we are reminded of the critical importance of awareness and proactive health measures in combating this formidable disease. Colorectal cancer remains a significant challenge, ranking as the third-leading...
Raising Awareness: Breast Cancer Insights from Dr. Erika Hamilton
Breast cancer awareness is not just about wearing pink ribbons; it's about understanding the disease, recognizing its risk factors, and supporting those affected by it. At the forefront of this crucial conversation is our very own medical oncologist, Dr. Erika...
SCRI Oncology Partners is Now Enrolling Patients on the Phase III TIGeR-PaC Clinical Trials for Patients with Locally Advanced Pancreatic Cancer
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Sarah Cannon Research Institute Appoints Director of Lymphoma Research
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Blood Advances
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL
SCRI Oncology Partners Launches New Center for Breast Health and High-Risk Clinic to Advance Care and Empower Patients
Nashville, Tenn. Sept. 24, 2025 — SCRI Oncology Partners, a leading cancer treatment center led by internationally renowned oncology experts, proudly announces the opening of its new Center for Breast Health, featuring a specialized High-Risk Clinic. This...
How to Detect Skin Cancer
Skin cancer is the most common form of cancer in the United States with more people being diagnosed each year than all other cancers combined. Knowing what to look for can help catch it early when it’s much easier to treat.
Six Must-Knows about Bladder Cancer
Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.
SCRI Oncology Partners Welcomes Hans Lee, MD, and Cody Lebeck Lee, MD to Provide Expert Cancer Care to Tennessee Community
SCRI Oncology Partners, a dedicated cancer treatment center led by globally recognized oncology experts, is proud to welcome Hans Lee, MD, and Cody Lebeck Lee, MD to the practice.
What to Know About Testicular Cancer
April is National Testicular Cancer Awareness Month, and at SCRI Oncology Partners, we recognize it is a crucial time to spotlight the importance of awareness and research in the fight against this disease. Testicular cancer predominantly impacts young and middle-aged...
The Importance of Health Screenings for Colorectal Cancer
As March ushers in National Colorectal Cancer Awareness Month, we are reminded of the critical importance of awareness and proactive health measures in combating this formidable disease. Colorectal cancer remains a significant challenge, ranking as the third-leading...
Raising Awareness: Breast Cancer Insights from Dr. Erika Hamilton
Breast cancer awareness is not just about wearing pink ribbons; it's about understanding the disease, recognizing its risk factors, and supporting those affected by it. At the forefront of this crucial conversation is our very own medical oncologist, Dr. Erika...
SCRI Oncology Partners is Now Enrolling Patients on the Phase III TIGeR-PaC Clinical Trials for Patients with Locally Advanced Pancreatic Cancer
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Sarah Cannon Research Institute Appoints Director of Lymphoma Research
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Blood Advances
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL
SCRI Oncology Partners Launches New Center for Breast Health and High-Risk Clinic to Advance Care and Empower Patients
Nashville, Tenn. Sept. 24, 2025 — SCRI Oncology Partners, a leading cancer treatment center led by internationally renowned oncology experts, proudly announces the opening of its new Center for Breast Health, featuring a specialized High-Risk Clinic. This...
How to Detect Skin Cancer
Skin cancer is the most common form of cancer in the United States with more people being diagnosed each year than all other cancers combined. Knowing what to look for can help catch it early when it’s much easier to treat.
Six Must-Knows about Bladder Cancer
Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.
SCRI Oncology Partners Welcomes Hans Lee, MD, and Cody Lebeck Lee, MD to Provide Expert Cancer Care to Tennessee Community
SCRI Oncology Partners, a dedicated cancer treatment center led by globally recognized oncology experts, is proud to welcome Hans Lee, MD, and Cody Lebeck Lee, MD to the practice.
What to Know About Testicular Cancer
April is National Testicular Cancer Awareness Month, and at SCRI Oncology Partners, we recognize it is a crucial time to spotlight the importance of awareness and research in the fight against this disease. Testicular cancer predominantly impacts young and middle-aged...
The Importance of Health Screenings for Colorectal Cancer
As March ushers in National Colorectal Cancer Awareness Month, we are reminded of the critical importance of awareness and proactive health measures in combating this formidable disease. Colorectal cancer remains a significant challenge, ranking as the third-leading...
Raising Awareness: Breast Cancer Insights from Dr. Erika Hamilton
Breast cancer awareness is not just about wearing pink ribbons; it's about understanding the disease, recognizing its risk factors, and supporting those affected by it. At the forefront of this crucial conversation is our very own medical oncologist, Dr. Erika...
SCRI Oncology Partners is Now Enrolling Patients on the Phase III TIGeR-PaC Clinical Trials for Patients with Locally Advanced Pancreatic Cancer
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Sarah Cannon Research Institute Appoints Director of Lymphoma Research
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Blood Advances
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL